Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease

被引:192
|
作者
Betz, RC
Planko, L
Eigelshoven, S
Hanneken, S
Pasternack, SM
Büssow, H
Van den Bogaert, K
Wenzel, J
Braun-Falco, M
Rütten, A
Rogers, MA
Ruzicka, T
Nöthen, MM
Magin, TM
Kruse, R
机构
[1] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany
[2] Univ Bonn, Inst Phys Chem, D-53111 Bonn, Germany
[3] Univ Bonn, Inst Anat, D-53111 Bonn, Germany
[4] Univ Bonn, Dept Gen, Life & Brain Ctr, D-53111 Bonn, Germany
[5] Univ Bonn, Dept Dermatol, D-53111 Bonn, Germany
[6] Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany
[7] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium
[8] Univ Freiburg, Dept Dermatol, Freiburg, Germany
[9] Lab Dermatohistopathol, Friedrichshafen, Germany
[10] German Canc Res Ctr, Sect Normal & Neoplast Epidermal Differentiat, D-6900 Heidelberg, Germany
关键词
D O I
10.1086/500850
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by progressive and disfiguring reticulate hyperpigmentation of the flexures. We performed a genomewide linkage analysis of two German families and mapped DDD to chromosome 12q, with a total LOD score of 4.42 (theta = 0.0) for marker D12S368. This region includes the keratin gene cluster, which we screened for mutations. We identified loss-of-function mutations in the keratin 5 gene (KRT5) in all affected family members and in six unrelated patients with DDD. These represent the first identified mutations that lead to haploinsufficiency in a keratin gene. The identification of loss-of-function mutations, along with the results from additional functional studies, suggest a crucial role for keratins in the organization of cell adhesion, melanosome uptake, organelle transport, and nuclear anchorage.
引用
收藏
页码:510 / 519
页数:10
相关论文
共 50 条
  • [31] Proposing GLMN, encoding glomulin, as a novel gene for Dowling-Degos disease
    Kumar, Sheetal
    Betz, Regina C.
    Frank, Jorge
    BRITISH JOURNAL OF DERMATOLOGY, 2025,
  • [32] Dowling-Degos disease: current research progress
    Ying-Da Wu
    Wen-Rui Li
    Wan-Lu Zhang
    Ping Cheng
    Cheng-Rang Li
    国际皮肤性病学杂志(英文), 2018, 1 (04) : 208 - 211
  • [33] Dowling-Degos disease presenting as hypopigmented macules
    Pickup, Tiffany L.
    Mutasim, Diya F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (06) : 1224 - 1225
  • [34] HABERS SYNDROME OR DOWLING-DEGOS DISEASE - REPLY
    KIKUCHI, I
    ARCHIVES OF DERMATOLOGY, 1982, 118 (04) : 214 - 214
  • [35] DOWLING-DEGOS DISEASE - INEFFICIENT THERAPY WITH RETINOIDS
    OPPOLZER, G
    SCHWARZ, T
    DUSCHET, P
    BRENNER, W
    GSCHNAIT, F
    HAUTARZT, 1987, 38 (10): : 615 - 618
  • [36] Effectiveness of topical adapalene in Dowling-Degos disease
    Altomare, G
    Capella, GL
    Fracchiolla, C
    Frigerio, E
    DERMATOLOGY, 1999, 198 (02) : 176 - 177
  • [37] DOWLING-DEGOS DISEASE - AN AUTOSOMALLY DOMINANT GENODERMATOSIS
    BILTZ, H
    KIESSLING, M
    ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1988, 63 (08): : 642 - 644
  • [38] ULTRASTRUCTURE OF PIGMENTARY CHANGES IN DOWLING-DEGOS DISEASE
    GROSSHANS, E
    GEIGER, JM
    JOURNAL OF CUTANEOUS PATHOLOGY, 1978, 5 (05) : 298 - 298
  • [39] A familial case of Dowling-Degos disease on the vulva
    Coco, V.
    Guerriero, C.
    Esposito, I.
    De Vincenzo, R. P.
    Peris, K.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (08) : 921 - 923
  • [40] To investigate a pedigree with Dowling-Degos disease and mutation analysis of ADAR gene
    Li, M.
    Dai, X.
    Yang, L.
    Zhu, X.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 75 - 75